Oooo - fractions! Sorry, but you already lost lots of people at that point.
As for their ability to read this:
To date, 343 (85%) pts remain on therapy, 60 (15%) have discontinued (42 BP/ALL): 24 (6%) progressive disease (20 BP/ALL); 11 (3%) AE (3 pain, 3 thrombocytopenia, 1 each haemorrhage, loss of consciousness, enterocolitis, cytokine release syndrome, hepatotoxicity/pleuro-pericardial effusion after overdose); 8 (2%) died (3 related; 7 BP/ALL); 17 (4%) other.
and realize that of those patients who did not have blast-phase ALL, exactly one died while on treatment and exactly four had their disease progress, well, I guess we'll have to wait for tomorrow for it to sink in....
EDIT: Personally, I'd like to know the overlap here:
8 (2%) died (3 related; 7 BP/ALL)
but ultimately, I think it will be of little importance.
(Someone please correct me if I'm misreading this!)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.